Nova Patents
AT333289T

Separation of active complexes

Abstract

(57) Summary book invention Lipid, cationic lipid, リポソーム, peptide, From the complex formed by the meeting with the transformer フェクティング ingredient and polynucleotide to which transfection activity like cationic peptide, a dendrimer, or the poly cation is made to increase, The active complex with clear composition which has the specific physicochemical feature like density, surface charge, or grain size is separated. In a desirable mode, super-centrifugality of the polynucleotide * transformer フェクティング ingredient complex is carried out, and one or more bands corresponding to the complex which has a specific polynucleotide * transformer フェクティング ingredient interaction are disassembled. The polynucleotide complex which has a cationic liposome transformer フェクティング ingredient is disassembled into two main bands corresponding to the formed complex under a superfluous lipid condition or superfluous polynucleotide conditions. In another mode, it is decomposed using an intersection flow electrophoresis, and a polynucleotide * transformer フェクティング ingredient complex has a complex which has a specific interaction identified, and is separated from a superfluous first ingredient.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Granted
  4. Today

79 members in 11 offices

This recordMember, by publication datePriority claim1 more office is in the list below

Priority claims1

Priority claims
DocumentOfficeKindDate
48211095United States of AmericaA

Members79

Family members, oldest first
DocumentOfficeKind
CA2133323A1CanadaA1
WO9319768A1World Intellectual Property Organization (WIPO)A1
AU4027893AAustraliaA
CA2163364A1CanadaA1
WO9502397A1World Intellectual Property Organization (WIPO)A1
EP0636028A1European Patent Office (EPO)A1
AU1240095AAustraliaA
JPH07505639AJapanA
EP0708637A1European Patent Office (EPO)A1
CA2223921A1CanadaA1
CA2223934A1CanadaA1
WO9640264A1World Intellectual Property Organization (WIPO)A1
WO9640265A1World Intellectual Property Organization (WIPO)A1
CA2224156A1CanadaA1
WO9641873A1World Intellectual Property Organization (WIPO)A1
AU5938196AAustraliaA
AU6024896AAustraliaA
JPH09500136AJapanA
AU5938296AAustraliaA
US5661025AUnited States of AmericaA
AU681735B2AustraliaB2
AU682308B2AustraliaB2
EP0831923A1European Patent Office (EPO)A1
EP0833667A1European Patent Office (EPO)A1
EP0836645A1European Patent Office (EPO)A1
EP0708637A4European Patent Office (EPO)A4
US5811406AUnited States of AmericaA
EP0636028A4European Patent Office (EPO)A4
AU2117999AAustraliaA
JPH11507922AJapanA
AU707734B2AustraliaB2
AU708179B2AustraliaB2
US5955365AUnited States of AmericaA
US5972600AUnited States of AmericaA
US5977084AUnited States of AmericaA
US5990089AUnited States of AmericaA
AU714526B2AustraliaB2
AU720187B2AustraliaB2
EP0831923A4European Patent Office (EPO)A4
US6113946AUnited States of AmericaA
JP2001516329AJapanA
JP2001517061AJapanA
US6300317B1United States of AmericaB1
EP0833667A4European Patent Office (EPO)A4
EP0836645A4European Patent Office (EPO)A4
AU681735CAustraliaC
EP1236473A2European Patent Office (EPO)A2
EP1236473A3European Patent Office (EPO)A3
JP2004000245AJapanA
EP0708637B1European Patent Office (EPO)B1
AT258434TAustriaT
ATE258434T1AustriaT1
EP0636028B1European Patent Office (EPO)B1
DE69433519D1GermanyD1
AT260679TAustriaT
ATE260679T1AustriaT1
DE69333434D1GermanyD1
DK0636028T3DenmarkT3
ES2211882T3SpainT3
PT636028EPortugalE
DE69433519T2GermanyT2
EP1491217A1European Patent Office (EPO)A1
ES2221920T3SpainT3
DE69333434T2GermanyT2
JP2005110696AJapanA
JP3688278B2JapanB2
JP3785187B2JapanB2
EP0831923B1European Patent Office (EPO)B1
AT333289TThis recordAustriaT
ATE333289T1AustriaT1
AU682308CAustraliaC
DE69636363D1GermanyD1
JP2007006899AJapanA
JP3907662B2JapanB2
JP3950472B2JapanB2
US7323297B1United States of AmericaB1
JP4074658B2JapanB2
CA2163364CCanadaC
CA2133323CCanadaC